A Growing Open Access Toolbox

Legal methods to retrieve paywalled articles for free are on the rise, but better self-archiving practices could help improve accessibility.

Written byDiana Kwon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ISTOCK, SORBETTOOver the past year, major publishers began to crack down on illegal means of accessing paywalled articles for free. In November, the American Chemical Society (ACS) won a default judgement in its case against Sci-Hub, a pirate site for scholarly literature. ResearchGate, an academic social network where many researchers post their published work, also faced legal action—in October, the ACS and Elsevier filed a lawsuit against the site for illegally hosting copyrighted material. ResearchGate then moved to restrict access to 1.7 million articles.

Together, these sites provide scientists access to a vast collection of academic publications: Sci-Hub alone hosts around 65 million research-related documents, such as journal articles and book chapters. “Sci-hub shows people how easy it should be to access scholarly literature,” says Joe McArthur, cofounder of the Open Access Button, a tool that helps researchers legally access articles behind paywalls. “Unfortunately, it is in no way sustainable, and we need to continue to work within the bounds of copyright law to make sure we have community-owned, open infrastructure for accessing research articles.”

Free alternatives to these sites are on the rise. McArthur is among a growing group of individuals who have developed legal means of retrieving paywalled scientific literature for free. These tools—free browser extensions that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies